文献速递衰弱、肌少症与跌倒老年综合评估

基于电子初级保健记录的经验证衰弱测量工具:诊断准确性综述

Validated frailty measures using electronic primary care records: a review of diagnostic test accuracy.
PubMed 文献 · Age Ageing · 2023-01-01

该系统性综述评估了初级保健中经验证的电子衰弱测量工具(VEFM)与面对面评估参考标准相比的灵敏度和特异度。共纳入10项研究,涉及电子衰弱指数(eFI)、基于理赔的衰弱指数(cFI)和多重用药三种工具,参考标准均为衰弱表型。eFI表现最佳但假阳性较多,现有电子衰弱工具可能不适合初级保健人群筛查。

要点

  • eFI灵敏度0.84、特异度0.78,但假阳性结果较多。
  • cFI汇总灵敏度0.48、特异度0.80,筛查能力有限。
  • 多重用药(≥5种药物)汇总灵敏度0.61、特异度0.66。

核心结论

  • eFI是表现最佳的VEFM,但基于英国全科诊所平均分析会产生大量假阳性结果。
  • 现有电子衰弱工具可能不适合用于初级保健为基础的人群筛查。

研究设计与样本

  • 系统性综述,检索Medline、Pubmed、CENTRAL、CINHAL和Embase,纳入比较初级保健VEFM与面对面评估的研究。
  • 共筛查2245条标题,最终纳入10项研究,使用QUADAS修订工具进行质量评估。

主要发现

  • 10项研究描述了三种指标测试:电子衰弱指数(eFI)、基于理赔的衰弱指数(cFI)和多重用药。
  • 每项研究的参考标准均为衰弱表型。
  • 一项60例患者研究评估eFI,灵敏度0.84(95%CI=0.55,0.98),特异度0.78(0.64,0.89)。
  • 两项7679例患者研究评估cFI,汇总灵敏度0.48(95%CI=0.23,0.74),特异度0.80(0.53,0.98)。
  • 七项34328例患者研究评估多重用药(定义为≥5种药物)作为筛查工具,汇总灵敏度0.61(95%CI=0.50,0.72),特异度0.66(0.58,0.73)。

关键数值与推荐

  • eFI:灵敏度0.84(95%CI=0.55,0.98),特异度0.78(0.64,0.89),基于60例患者研究。
  • cFI:汇总灵敏度0.48(95%CI=0.23,0.74),特异度0.80(0.53,0.98),基于7679例患者两项研究。
  • 多重用药(≥5种药物):汇总灵敏度0.61(95%CI=0.50,0.72),特异度0.66(0.58,0.73),基于34328例患者七项研究。

临床怎么用

  • 在初级保健中使用电子衰弱工具筛查时需警惕假阳性结果,eFI虽表现最佳但假阳性较多。
  • 现有电子衰弱工具可能不适用于人群筛查,临床决策应结合面对面评估。

局限性

  • 纳入研究数量较少(10项),部分工具(如eFI)仅基于小样本研究。
  • 参考标准均为衰弱表型,可能限制对其他衰弱定义的推广性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Identification of people who have or are at risk of frailty enables targeted interventions, and the use of tools that screen for frailty using electronic records (which we term as validated electronic frailty measures (VEFMs)) within primary care is incentivised by NHS England. We carried out a systematic review to establish the sensitivity and specificity of available primary care VEFMs when compared to a reference standard in-person assessment. METHODS: Medline, Pubmed, CENTRAL, CINHAL and Embase searches identified studies comparing a primary care VEFM with in-person assessment. Studies were quality assessed using Quality Assessment of Diagnostic Accuracy Studies revised tool. Sensitivity and specificity values were extracted or were calculated and pooled using StatsDirect. RESULTS: There were 2,245 titles screened, with 10 studies included. These described three different index tests: electronic frailty index (eFI), claims-based frailty index (cFI) and polypharmacy. Frailty Phenotype was the reference standard in each study. One study of 60 patients examined the eFI, reporting a sensitivity of 0.84 (95% CI = 0.55, 0.98) and a specificity of 0.78 (0.64, 0.89). Two studies of 7,679 patients examined cFI, with a pooled sensitivity of 0.48 (95% CI = 0.23, 0.74) and a specificity of 0.80 (0.53, 0.98). Seven studies of 34,328 patients examined a polypharmacy as a screening tool (defined as more than or equal to five medications) with a pooled sensitivity of 0.61 (95% CI = 0.50, 0.72) and a specificity of 0.66 (0.58, 0.73). CONCLUSIONS: eFI is the best-performing VEFM; however, based on our analysis of an average UK GP practice, it would return a high number of false-positive results. In conclusion, existing electronic frailty tools may not be appropriate for primary care-based population screening.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Brack C, Kynn M, Murchie P, et al. Validated frailty measures using electronic primary care records: a review of diagnostic test accuracy. Age Ageing. 2023. PMID: 37993406. doi:10.1093/ageing/afad173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。